`
`
`October 17, 2023
`
` Aziz Burgy
`AXINN, VELTROP &
`HARKRIDER LLP
`1901 L Street NW
`Washington, DC 20036
`aburgy@axinn.com
`
`902 Broadway
`18th Floor
`New York, NY 10010-6035
`Erica R. Sutter
`esutter@fenwick.com | 650.335.7626
`
`212.430.2600
`Fenwick.com
`
`
`Stephen R. Auten
`TAFT STETTINIUS &
`HOLLISTER LLP
`111 East Wacker Drive,
`Suite 2800
`Chicago, IL 60601-3713
`sauten@taftlaw.com
`
`Brian Sodikoff
`KATTEN MUCHIN ROSENMAN LLP
`525 West Monroe Street
`Chicago, IL 60661-3693
`brian.sodikoff@katten.com
`
`Michael J. Gaertner
`LOCKE LORD LLP
`111 South Wacker Drive
`Chicago, IL 60606
`mgaertner@lockelord.com
`
`Sharon Lin
`WINSTON & STRAWN LLP
`1901 L Street N.W.
`Washington, DC 20036
`slin@winston.com
`
`Brandon M. White
`PERKINS COIE LLP
`700 13th Street NW, Suite 800
`Washington, DC 20005
`bmwhite@perkinscoie.com
`
`Re:
`
`
`In re: Ozempic (Semaglutide) Patent Litigation, MDL No. 3038; C.A. No. 22-294-
`CFC (Consolidated); C.A. No. 22-1040-CFC (D. Del.)
`
`
`
`Dear Counsel:
`
`Plaintiffs Novo Nordisk Inc. and Novo Nordisk A/S (collectively, “Novo Nordisk”)
`hereby make the following production:
`
`Bates Range
`NN-OZEM-004766890 – NN-OZEM-004775234
`NN-OZEM-004775235 – NN-OZEM-004804104
`
`Production Volume
`NN-OZEM007
`NN-OZEM008
`
`This production is made pursuant to the Protective Order entered in the above actions
`(see C.A. No. 22-cv-294-CFC, D.I. 50; C.A. No. 22-cv-1040-CFC, D.I. 53) and should be
`treated accordingly.
`Any inadvertent production of documents protected from disclosure by the attorney
`client privilege, the work product doctrine, or any other applicable privilege or protection shall
`not be deemed a waiver by Novo Nordisk of any such privilege or protection.
`This production may be accessed via ftp at the address, and using the credentials,
`provided below. The production will be available for download for 7 days. A password to
`access the individual zip files will follow separately. Please let us know if you encounter any
`issues accessing the production.
`
`FTP Address:
`Username:
`Password:
`
`
`
`
`
`
`
`
`
`
`
`Novo Nordisk Exhibit 2019
`Dr. Reddy's Laboratories v. Novo Nordisk A/S
`IPR2024-00009
`Page 00001
`
`
`
`
`
`October 17, 2023
`Page 2
`
`Sincerely,
`
`/s/ Erica R. Sutter
`
`Erica R. Sutter
`
`cc: All Counsel of Record
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
